Neuroendocrine Carcinoma Classification
Mostrando 1-7 de 7 artigos, teses e dissertações.
-
1. Esthesioneuroblastoma, Neuroendocrine Carcinoma, and Sinonasal Undifferentiated Carcinoma: Differentiation in Diagnosis and Treatment
Introduction Malignant sinonasal tumors comprise less than 1% of all neoplasms. A wide variety of tumors occurring primarily in this site can present with an undifferentiated or poorly differentiated morphology. Among them are esthesioneuroblastomas, sinonasal undifferentiated carcinomas, and neuroendocrine carcinomas. Objectives We will discuss diagnos
Int. Arch. Otorhinolaryngol.. Publicado em: 2014
-
2. Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases
OBJECTIVE: Description of some of the clinical pathological characteristics of neuroendocrine tumors of the gastroenteropancreatic tract in Brazilian patients. INTRODUCTION: Neuroendocrine tumors arise in many organs and share common pathological features. In 2010, the World Health Organization published a new classification for neuroendocrine tumors using a
Clinics. Publicado em: 2011
-
3. Individual risk prediction of node and distant metastasis based on lymphangiogenic intensity in typical pulmonary carcinoid tumor / Predição do risco individual de metástase linfática e hematogênica em função da intensidade da linfangiogênese no tumor carcinóide típico broncopulmonar
Typical pulmonary carcinoids are neuroendocrine cells proliferations and they were former considered lung adenomas with no hematogenic or lymphatic metastatic potential. However, it is known that up to 20% of patients develop metastatic disease. It is mandatory that new studies be developed due to the variation in clinical presentation of these patients. It
Publicado em: 2008
-
4. Expression of somatostatin receptor type 2 (SSTR-2) and its relation with lymphatic metastasis and preoperative clinical features in typical bronchopulmonary carcinoid tumors / Expressão de receptores de somatostatina subtipo 2 (SSTR-2) e a sua relação com metástase linfática e variáveis clínicas pré-operatórias em tumores carcinóides broncopulmonares típicos
Os tumores carcinóides broncopulmonares típicos (CT) são proliferações de células neuroendócrinas. Foram consideradas como adenomas e acreditava-se que não tinham potencial para disseminação hematogênica e linfática. Porém, a ocorrência de metástase linfática e hematogênica acontece em um quinto dos indivíduos acometidos por essa patologia.
Publicado em: 2008
-
5. Study of the correlation between metastasis incidence in typical bronchopulmonary carcinoid tumors and clinical features, tissue biomarkers and index risk / Estudo da correlação entre a incidência de metástases em tumores carcinóides típicos broncopulmonares e biomarcadores teciduais, variáveis clínicas e índice de risco
Carcinóides típicos são proliferações de células neuroendócrinas. Discute-se se são carcinomas ou adenomas, devido ao seu comportamento ambíguo. É imperativo conhecer seu potencial maligno para que se estabeleça o tratamento adequado. Os relatos de metástase exigem uma definição de quais são os critérios que podem ser utilizados para prever o
Publicado em: 2004
-
6. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
We have generated a molecular taxonomy of lung carcinoma, the leading cause of cancer death in the United States and worldwide. Using oligonucleotide microarrays, we analyzed mRNA expression levels corresponding to 12,600 transcript sequences in 186 lung tumor samples, including 139 adenocarcinomas resected from the lung. Hierarchical and probabilistic clust
The National Academy of Sciences.
-
7. A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype
Human neuroendocrine cancers (NECs) arise in various endoderm-derived epithelia, have diverse morphologic features, exhibit a wide range of growth phenotypes, and generally have obscure cellular origins and ill-defined molecular mediators of initiation and progression. We describe a transgenic mouse model of metastatic gastric cancer initiated by expressing
National Academy of Sciences.